Details of the Drug Formulaction

General Information of Drug Formulation (ID: F07984)

• Formulation Name: Fenofibrate 145 mg tablet
• Company: Lake Eire Medical & Surgical Supply DBA Quality Care Products; Teva Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Fenofibrate	(DMFKXDY)	Coronary atherosclerosis		Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Docusate sodium	(E00563)	23673837	Surfactant
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Polyvinyl alcohol	(E00666)	Not Available	Coating agent; Emulsion stabilizing agent; Film/Membrane-forming agent
Saccharose	(E00091)	5988	Binding agent; Coating agent; Cryoprotectant; Diluent; Flavoring agent; Suspending agent; Viscosity-controlling agent
Sodium lauryl sulfate	(E00464)	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent